{"id":"W3203864709","doi":"10.1200/jco.21.00838","title":"Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Royal Victoria Regional Health Centre; Ottawa Hospital; Royal Victoria Hospital; University of Ottawa","funders":"National Cancer Institute; Pharmacyclics","keywords":"Rituximab; Medicine; Ibrutinib; Internal medicine; Placebo; Waldenstrom macroglobulinemia; Clinical endpoint; Adverse effect; Regimen; Gastroenterology; Surgery; Oncology; Randomized controlled trial; Lymphoma; Chronic lymphocytic leukemia; Leukemia; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01029327,0.002180903,0.005050709,0.0007110524,0.0003946869,0.001755299,0.001425279,0.001664563,0.004320809],"category_scores_gemma":[0.005876877,0.000845204,0.006390751,0.0006263727,0.0008928469,0.001024801,0.0008075136,0.002433521,0.0008022541],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009460065,"about_ca_system_score_gemma":0.001258479,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007092674,"about_ca_topic_score_gemma":0.001372955,"domain_scores_codex":[0.9948922,0.003794919,0.0002303415,0.0003535881,0.0003582641,0.0003705897],"domain_scores_gemma":[0.9966668,0.001526089,0.0006948892,0.0003556221,0.0002652875,0.000491238],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9838052,0.001431469,0.0007911706,0.0003814426,0.004367224,0.00002134574,0.0000252069,0.0005195296,0.00108669,0.00007943304,0.0008139099,0.006677292],"study_design_scores_gemma":[0.9359611,0.05156176,0.004988318,0.00005142532,0.004682843,0.0000430628,0.00002298839,0.0007476755,0.0004270959,0.0002063757,0.001278651,0.00002878338],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9579244,0.01640398,0.003717541,0.001239795,0.0008269395,0.0083582,0.006842634,0.0003188744,0.004367667],"genre_scores_gemma":[0.9711109,0.004657521,0.004228142,0.001739916,0.0006960419,0.00745673,0.006731343,0.0001092576,0.003269996],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01029327,"threshold_uncertainty_score":0.05443668,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2018638911413591,"score_gpt":0.5228453159033778,"score_spread":0.3209814247620187,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}